4178 — StemCyte International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for StemCyte International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	C2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	517	1,164	2,263	2,092
Net Total Accounts Receivable
Net Total Receivables	105	115	112	96.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,107	1,725	2,836	2,610
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	161	164	376	324
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,491	2,017	3,368	3,090
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	231	254	255	250
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1,136	1,181	1,418	1,351
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	355	836	1,949	1,739
Total Liabilities & Shareholders' Equity	1,491	2,017	3,368	3,090
Total Common Shares Outstanding